Edgar Wachenheim III
Greenhaven Associates
Edgar Wachenheim III Meritage Corp stake
total: 102
Greenhaven Associates MTH trades
- Total transactions:
- 25
- New positions:
- 3
- Sold out:
- 2
- Added:
- 12
- Reduced:
- 8
- Held since:
- 2022 Q2
- Held for:
- 17 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Edgar Wachenheim III holds 1,297,494 Meritage Corp (MTH) shares with a market value of roughly $108.79M accounting for 1.26% of the overall portfolio. To date, the estimated cost basis is nearly $72.73 for "buy" trades and estimated average "sell" price is $108.99. Greenhaven Associates first purchased MTH in 2018 Q2, initially acquiring 66,760 shares. Edgar Wachenheim III later completely sold out the position and invested in Meritage Corp again in 2022 Q2. Since the initial investment in Meritage Corp (MTH), Greenhaven Associates has made 24 more transactions.
When did Edgar Wachenheim III buy Meritage Corp (MTH)?
Edgar Wachenheim III first invested in Meritage Corp (MTH) in 2018 Q2 at the reported quarter-end price of $43.95 per share.
What's the cost basis of Greenhaven Associates's MTH stake?
The estimated cost basis for Meritage Corp (MTH) stake is around $72.73 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $72.73
- Weighted AVG sell price:
- $108.99
Edgar Wachenheim III's historical trades in Meritage Corp
25 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.26%
|
1,297,494
|
$83.85
|
$108,794,872
|
-10.82% (-157,355)
|
-0.22%
|
|
2026 Q1
|
1.48%
|
1,454,849
|
$61.84
|
$89,967,862
|
-0.72% (-10,491)
|
-0.01%
|
|
2025 Q4
|
1.56%
|
1,465,340
|
$65.80
|
$96,419,372
|
+0.85% (+12,386)
|
+0.01%
|
|
2025 Q3
|
1.60%
|
1,452,954
|
$72.43
|
$105,237,458
|
-2.61% (-39,001)
|
-0.04%
|
|
2025 Q2
|
1.49%
|
1,491,955
|
$66.97
|
$99,916,226
|
+4.01% (+57,587)
|
+0.06%
|
|
2025 Q1
|
1.62%
|
1,434,368
|
$70.88
|
$101,668,004
|
+94.09% (+695,355)
|
+0.78%
|
|
2024 Q4
|
1.68%
|
739,013
|
$153.82
|
$113,674,980
|
-0.72% (-5,350)
|
-0.01%
|
|
2024 Q3
|
1.79%
|
744,363
|
$205.07
|
$152,646,520
|
-3.60% (-27,790)
|
-0.07%
|
|
2024 Q2
|
1.64%
|
772,153
|
$161.85
|
$124,972,963
|
-6.62% (-54,752)
|
-0.08%
|
|
2024 Q1
|
1.34%
|
826,905
|
$175.46
|
$145,088,751
|
+0.01% (+114)
|
+0%
|
|
2023 Q4
|
1.54%
|
$174.20
|
+1.58% (+12,841)
|
|||
|
2023 Q3
|
1.29%
|
$122.39
|
+0.38% (+3,059)
|
|||
|
2023 Q2
|
1.53%
|
$142.27
|
+0.05% (+440)
|
|||
|
2023 Q1
|
1.47%
|
$116.76
|
-1.13% (-9,300)
|
|||
|
2022 Q4
|
1.34%
|
$92.20
|
+3.38% (+26,766)
|
|||
|
2022 Q3
|
1.17%
|
$70.27
|
+7.95% (+58,426)
|
|||
|
2022 Q2
|
1.15%
|
$72.50
|
new
|
|||
|
2020 Q3
|
0.00%
|
$76.12
|
-100% (-32,700)
|
|||
|
2020 Q2
|
0.06%
|
$76.12
|
new
|
|||
|
2019 Q3
|
0.00%
|
$51.34
|
-100% (-96,717)
|
|||
|
2019 Q2
|
0.09%
|
$51.34
|
+0.93% (+892)
|
|||
|
2019 Q1
|
0.08%
|
$44.71
|
+30.69% (+22,500)
|
|||
|
2018 Q4
|
0.05%
|
$36.71
|
-0.68% (-500)
|
|||
|
2018 Q3
|
0.05%
|
$39.91
|
+10.58% (+7,065)
|
|||
|
2018 Q2
|
0.04%
|
$43.95
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.